НовостиBenzingaRBC Capital Maintains Outperform on Ardent Health, Raises Price Target to $18 RBC Capital Maintains Outperform on Ardent Health, Raises Price Target to $18 Benzinga 2026.11.06 17:45 (GMT+0) Открыть на Benzinga Другие новости